Hormonal and volumetric long term control of a growth hormone-releasing hormone-producing carcinoid tumor

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 9, 1999, Pages 3162-3169

  Van Den Bruel, A ^a   Fevery, J ^a   Van Dorpe, J ^a   Hofland, L ^b   Bouillon, R ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; GROWTH HORMONE; OCTREOTIDE;

ACROMEGALY; ADULT; ARTICLE; CARCINOID; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; FEMALE; FOLLOW UP; HEADACHE; HORMONE RELEASE; HUMAN; PRIORITY JOURNAL; SWEATING; TREATMENT FAILURE;

EID: 0033305296     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.9.6001     Document Type: Article

References (18)

1. Ectopic acromegaly
2. Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid
3. Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone- and α-subunit-secreting tumors from acromegalic patients responsive to octreotide
4. Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: Superiority of continuous versus intermittent administration to control hormonal secretion
5. Ectopic acromegaly
6. Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumor: In vitro responses to GHRH and GHRP-6
7. Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid
8. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary and islet cell tumors
9. Somatostatin receptor scintigraphy of GBP tumors
10. Effect of somatostatin on abnormal growth hormone and prolactin secretion in patients with the carcinoid syndrome
11. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor
12. Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-995
13. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumor secreting growth hormone releasing factor
14. Measurement of human growth hormone- and corticotropin-releasing hormone
15. Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue
16. Pituitary and ectopic GRF mediated acromegaly treated with somatostatin analog, SMS 201-995
17. Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion
18. Long-term treatment of a metastasizing GRFoma with a somatostatin analogue (SMS 201-995) in a girl with gigantism